SGGPO
On the afternoon of October 27, the Ministry of Health informed the press after receiving reports that many medical facilities nationwide are currently lacking medicine, partly due to the delay in centralized bidding results and price negotiations.
 |
Clarifying the above information, Mr. Le Thanh Dung, Director of the National Drug Bidding Center, Ministry of Health, said that the National Drug Bidding Center is responsible for centralized national bidding for generic drugs of group 1 and group 2 of 32 active ingredients in the list of drugs to be bid. For the national centralized bidding, the majority (88/106 drugs) have had results since August 3, 2022 and will be effective from September 1, 2022 to August 31, 2024.
"Thus, the results have been implemented for more than 1 year and the implementation time is nearly 1 year. Furthermore, the center only organizes bidding for generic drugs of group 1 and group 2 of 32 active ingredients out of a total of 1,226 active ingredients in the list of drugs for bidding. Therefore, most of the demand for drugs for treatment is implemented by local centralized procurement units or by medical facilities themselves organizing bidding," Mr. Le Thanh Dung shared.
 |
Many public health facilities are experiencing shortages of certain drugs. |
For drugs with negotiated prices, the winning bids for 64 generic drugs have been announced in 4 phases and the framework agreement for phase 1 is effective from November 15, 2022 to November 14, 2024 and phase 4 is from April 17, 2023 to April 16, 2025. However, price negotiation is a form of bidding with a complicated process, many difficulties, and there is no regulation on the time for announcing the results.
At the same time, the number of drugs on the list that are subject to price negotiation is very large, including 701 drugs, so the Center has developed a plan and roadmap suitable to the time conditions of the Price Negotiation Council and the number of staff performing price negotiation (increased from 4 drugs in 2021 to 64 drugs for 1 negotiation round in 2022).
"While the results of the national centralized bidding and price negotiations have not been announced, medical facilities are allowed to organize bidding to ensure drug supply for treatment needs according to regulations of the Ministry of Health. The Center always has written notices on the progress of centralized procurement and requests medical facilities to proactively purchase drugs for medical examination and treatment," emphasized Mr. Le Thanh Dung.
 |
The Ministry of Health recommends that hospitals and localities be more proactive in purchasing and bidding for drugs. |
Regarding the next implementation plan of the National Drug Bidding Center in the coming time, Mr. Le Thanh Dung said that for the national centralized bidding for 50 drugs in the list of centrally bid drugs, the center is reviewing the list to continue organizing the selection of contractors to supply drugs to medical facilities. The expected time to supply drugs to facilities is from September 1, 2024 to August 31, 2026.
Regarding price negotiations with generic drugs, the center is finalizing the contractor selection plan for 86 drugs, expected to be submitted to the Ministry of Health for approval in November 2023. At the same time, the center plans to synthesize the needs of medical facilities nationwide for 64 generic drugs whose Framework Agreements will expire at the end of 2024 and early 2025.
Source
Comment (0)